Nu Med Plus Stock Short Ratio

NUMD Stock  USD 0.01  0.0001  1.25%   
Nu Med Plus fundamentals help investors to digest information that contributes to Nu-Med Plus' financial success or failures. It also enables traders to predict the movement of Nu-Med OTC Stock. The fundamental analysis module provides a way to measure Nu-Med Plus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nu-Med Plus otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nu Med Plus OTC Stock Short Ratio Analysis

Nu-Med Plus' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

 = 

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition

Based on the latest financial disclosure, Nu Med Plus has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The short ratio for all United States stocks is 100.0% higher than that of the company.

Nu-Med Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu-Med Plus' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nu-Med Plus could also be used in its relative valuation, which is a method of valuing Nu-Med Plus by comparing valuation metrics of similar companies.
Nu Med is currently under evaluation in short ratio category among its peers.

Nu-Med Fundamentals

About Nu-Med Plus Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nu Med Plus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu-Med Plus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Med Plus based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Nu-Med OTC Stock

Nu-Med Plus financial ratios help investors to determine whether Nu-Med OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nu-Med with respect to the benefits of owning Nu-Med Plus security.